Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-010084

CHIEF ACCOUNTING OFFICER gave up 1,084 shares (to pay taxes)

  • CHIEF ACCOUNTING OFFICER acquired 2,558 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-04-01 Option exercise +2,558 20,146 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-04-01 Shares withheld for taxes −1,084 $19.70 $21,355 19,062 D
Derivatives
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-04-01 Option exercise · Restricted Share Unit −2,558 7,672 D
Loading xslF345X05/form4-04032024_090431.xml…